These genes, namely CTNNB1, HDAC1, CREBBP, PIK3R1, PRKACA, MAPK14, NR3C1, GNAQ, STAT3, and DCN, have previous implications in lung cancer, serving as potential early diagnostic and therapeutic biomarkers (19–23). Here, PRKACA is linked to lung carcinoma.